MEK1/2 inhibitors in the treatment of gynecologic malignancies
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference61 articles.
1. Mammalian MAP kinase signalling cascades;Chang;Nature,2001
2. Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases;Takekawa;Mol Cell,2005
3. MEK and the inhibitors: from bench to bedside;Akinleye;J Hematol Oncol,2013
4. Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors;Fischmann;Biochemistry,2009
5. Targeting MAPK pathway in melanoma therapy;Cheng;Cancer Metastasis Rev,2013
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers;Cells;2024-06-19
2. Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti–PD‐L1, for BRCA wild‐type, platinum‐sensitive, recurrent ovarian cancer;Cancer;2024-01-30
3. In silicoscreening of inhibitors for MEK1 from alkaloids using swissdock software for human lung carcinoma;AIP Conference Proceedings;2024
4. New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings;International Journal of Gynecologic Cancer;2023-12-14
5. Upregulation of cIAP1 induced by AZD8330 alleviates osteoarthritis progression by inhibiting the RIP1-associated necrosis signaling pathway;International Immunopharmacology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3